0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Latent Tuberculosis Infection Screening Test Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-9U15029
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Latent Tuberculosis Infection Screening Test Market Research Report 2023
BUY CHAPTERS

Global Latent Tuberculosis Infection Screening Test Market Research Report 2025

Code: QYRE-Auto-9U15029
Report
May 2025
Pages:71
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Latent Tuberculosis Infection Screening Test Market

The global market for Latent Tuberculosis Infection Screening Test was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Latent tuberculosis infection (LTBI) screening tests are diagnostic tests used to identify individuals who have been infected with the bacteria that cause tuberculosis (TB) but do not have any active symptoms of the disease. LTBI screening is crucial for early detection and treatment of latent infections to prevent the development of active TB disease and transmission to others.
North American market for Latent Tuberculosis Infection Screening Test is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Latent Tuberculosis Infection Screening Test is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Latent Tuberculosis Infection Screening Test in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Latent Tuberculosis Infection Screening Test include Qiagen, Oxford Immunotec, Bio-Rad Laboratories, Thermo Fisher Scientific, Sanofi, Par Sterile, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Latent Tuberculosis Infection Screening Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Latent Tuberculosis Infection Screening Test.
The Latent Tuberculosis Infection Screening Test market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Latent Tuberculosis Infection Screening Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Latent Tuberculosis Infection Screening Test companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Latent Tuberculosis Infection Screening Test Market Report

Report Metric Details
Report Name Latent Tuberculosis Infection Screening Test Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Qiagen, Oxford Immunotec, Bio-Rad Laboratories, Thermo Fisher Scientific, Sanofi, Par Sterile
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Latent Tuberculosis Infection Screening Test company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Latent Tuberculosis Infection Screening Test Market report?

Ans: The main players in the Latent Tuberculosis Infection Screening Test Market are Qiagen, Oxford Immunotec, Bio-Rad Laboratories, Thermo Fisher Scientific, Sanofi, Par Sterile

What are the Application segmentation covered in the Latent Tuberculosis Infection Screening Test Market report?

Ans: The Applications covered in the Latent Tuberculosis Infection Screening Test Market report are Hospital, Diagnostic Laboratories, Others

What are the Type segmentation covered in the Latent Tuberculosis Infection Screening Test Market report?

Ans: The Types covered in the Latent Tuberculosis Infection Screening Test Market report are Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA)

Recommended Reports

Tuberculosis Diagnostics

Infectious Disease Testing

Screening & Lab Services

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Latent Tuberculosis Infection Screening Test Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tuberculin Skin Test (TST)
1.2.3 Interferon Gamma Released Assay (IGRA)
1.3 Market by Application
1.3.1 Global Latent Tuberculosis Infection Screening Test Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Latent Tuberculosis Infection Screening Test Market Perspective (2020-2031)
2.2 Global Latent Tuberculosis Infection Screening Test Growth Trends by Region
2.2.1 Global Latent Tuberculosis Infection Screening Test Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Latent Tuberculosis Infection Screening Test Historic Market Size by Region (2020-2025)
2.2.3 Latent Tuberculosis Infection Screening Test Forecasted Market Size by Region (2026-2031)
2.3 Latent Tuberculosis Infection Screening Test Market Dynamics
2.3.1 Latent Tuberculosis Infection Screening Test Industry Trends
2.3.2 Latent Tuberculosis Infection Screening Test Market Drivers
2.3.3 Latent Tuberculosis Infection Screening Test Market Challenges
2.3.4 Latent Tuberculosis Infection Screening Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Latent Tuberculosis Infection Screening Test Players by Revenue
3.1.1 Global Top Latent Tuberculosis Infection Screening Test Players by Revenue (2020-2025)
3.1.2 Global Latent Tuberculosis Infection Screening Test Revenue Market Share by Players (2020-2025)
3.2 Global Latent Tuberculosis Infection Screening Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Latent Tuberculosis Infection Screening Test Revenue
3.4 Global Latent Tuberculosis Infection Screening Test Market Concentration Ratio
3.4.1 Global Latent Tuberculosis Infection Screening Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Latent Tuberculosis Infection Screening Test Revenue in 2024
3.5 Global Key Players of Latent Tuberculosis Infection Screening Test Head office and Area Served
3.6 Global Key Players of Latent Tuberculosis Infection Screening Test, Product and Application
3.7 Global Key Players of Latent Tuberculosis Infection Screening Test, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Latent Tuberculosis Infection Screening Test Breakdown Data by Type
4.1 Global Latent Tuberculosis Infection Screening Test Historic Market Size by Type (2020-2025)
4.2 Global Latent Tuberculosis Infection Screening Test Forecasted Market Size by Type (2026-2031)
5 Latent Tuberculosis Infection Screening Test Breakdown Data by Application
5.1 Global Latent Tuberculosis Infection Screening Test Historic Market Size by Application (2020-2025)
5.2 Global Latent Tuberculosis Infection Screening Test Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Latent Tuberculosis Infection Screening Test Market Size (2020-2031)
6.2 North America Latent Tuberculosis Infection Screening Test Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Latent Tuberculosis Infection Screening Test Market Size by Country (2020-2025)
6.4 North America Latent Tuberculosis Infection Screening Test Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Latent Tuberculosis Infection Screening Test Market Size (2020-2031)
7.2 Europe Latent Tuberculosis Infection Screening Test Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Latent Tuberculosis Infection Screening Test Market Size by Country (2020-2025)
7.4 Europe Latent Tuberculosis Infection Screening Test Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Latent Tuberculosis Infection Screening Test Market Size (2020-2031)
8.2 Asia-Pacific Latent Tuberculosis Infection Screening Test Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Latent Tuberculosis Infection Screening Test Market Size by Region (2020-2025)
8.4 Asia-Pacific Latent Tuberculosis Infection Screening Test Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Latent Tuberculosis Infection Screening Test Market Size (2020-2031)
9.2 Latin America Latent Tuberculosis Infection Screening Test Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Latent Tuberculosis Infection Screening Test Market Size by Country (2020-2025)
9.4 Latin America Latent Tuberculosis Infection Screening Test Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size (2020-2031)
10.2 Middle East & Africa Latent Tuberculosis Infection Screening Test Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size by Country (2020-2025)
10.4 Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Qiagen
11.1.1 Qiagen Company Details
11.1.2 Qiagen Business Overview
11.1.3 Qiagen Latent Tuberculosis Infection Screening Test Introduction
11.1.4 Qiagen Revenue in Latent Tuberculosis Infection Screening Test Business (2020-2025)
11.1.5 Qiagen Recent Development
11.2 Oxford Immunotec
11.2.1 Oxford Immunotec Company Details
11.2.2 Oxford Immunotec Business Overview
11.2.3 Oxford Immunotec Latent Tuberculosis Infection Screening Test Introduction
11.2.4 Oxford Immunotec Revenue in Latent Tuberculosis Infection Screening Test Business (2020-2025)
11.2.5 Oxford Immunotec Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Latent Tuberculosis Infection Screening Test Introduction
11.3.4 Bio-Rad Laboratories Revenue in Latent Tuberculosis Infection Screening Test Business (2020-2025)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Latent Tuberculosis Infection Screening Test Introduction
11.4.4 Thermo Fisher Scientific Revenue in Latent Tuberculosis Infection Screening Test Business (2020-2025)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Latent Tuberculosis Infection Screening Test Introduction
11.5.4 Sanofi Revenue in Latent Tuberculosis Infection Screening Test Business (2020-2025)
11.5.5 Sanofi Recent Development
11.6 Par Sterile
11.6.1 Par Sterile Company Details
11.6.2 Par Sterile Business Overview
11.6.3 Par Sterile Latent Tuberculosis Infection Screening Test Introduction
11.6.4 Par Sterile Revenue in Latent Tuberculosis Infection Screening Test Business (2020-2025)
11.6.5 Par Sterile Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Latent Tuberculosis Infection Screening Test Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Tuberculin Skin Test (TST)
 Table 3. Key Players of Interferon Gamma Released Assay (IGRA)
 Table 4. Global Latent Tuberculosis Infection Screening Test Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Latent Tuberculosis Infection Screening Test Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Latent Tuberculosis Infection Screening Test Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Latent Tuberculosis Infection Screening Test Market Share by Region (2020-2025)
 Table 8. Global Latent Tuberculosis Infection Screening Test Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Latent Tuberculosis Infection Screening Test Market Share by Region (2026-2031)
 Table 10. Latent Tuberculosis Infection Screening Test Market Trends
 Table 11. Latent Tuberculosis Infection Screening Test Market Drivers
 Table 12. Latent Tuberculosis Infection Screening Test Market Challenges
 Table 13. Latent Tuberculosis Infection Screening Test Market Restraints
 Table 14. Global Latent Tuberculosis Infection Screening Test Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Latent Tuberculosis Infection Screening Test Market Share by Players (2020-2025)
 Table 16. Global Top Latent Tuberculosis Infection Screening Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latent Tuberculosis Infection Screening Test as of 2024)
 Table 17. Ranking of Global Top Latent Tuberculosis Infection Screening Test Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Latent Tuberculosis Infection Screening Test Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Latent Tuberculosis Infection Screening Test, Headquarters and Area Served
 Table 20. Global Key Players of Latent Tuberculosis Infection Screening Test, Product and Application
 Table 21. Global Key Players of Latent Tuberculosis Infection Screening Test, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Latent Tuberculosis Infection Screening Test Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Latent Tuberculosis Infection Screening Test Revenue Market Share by Type (2020-2025)
 Table 25. Global Latent Tuberculosis Infection Screening Test Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Latent Tuberculosis Infection Screening Test Revenue Market Share by Type (2026-2031)
 Table 27. Global Latent Tuberculosis Infection Screening Test Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Latent Tuberculosis Infection Screening Test Revenue Market Share by Application (2020-2025)
 Table 29. Global Latent Tuberculosis Infection Screening Test Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Latent Tuberculosis Infection Screening Test Revenue Market Share by Application (2026-2031)
 Table 31. North America Latent Tuberculosis Infection Screening Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Latent Tuberculosis Infection Screening Test Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Latent Tuberculosis Infection Screening Test Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Latent Tuberculosis Infection Screening Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Latent Tuberculosis Infection Screening Test Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Latent Tuberculosis Infection Screening Test Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Latent Tuberculosis Infection Screening Test Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Latent Tuberculosis Infection Screening Test Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Latent Tuberculosis Infection Screening Test Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Latent Tuberculosis Infection Screening Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Latent Tuberculosis Infection Screening Test Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Latent Tuberculosis Infection Screening Test Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Qiagen Company Details
 Table 47. Qiagen Business Overview
 Table 48. Qiagen Latent Tuberculosis Infection Screening Test Product
 Table 49. Qiagen Revenue in Latent Tuberculosis Infection Screening Test Business (2020-2025) & (US$ Million)
 Table 50. Qiagen Recent Development
 Table 51. Oxford Immunotec Company Details
 Table 52. Oxford Immunotec Business Overview
 Table 53. Oxford Immunotec Latent Tuberculosis Infection Screening Test Product
 Table 54. Oxford Immunotec Revenue in Latent Tuberculosis Infection Screening Test Business (2020-2025) & (US$ Million)
 Table 55. Oxford Immunotec Recent Development
 Table 56. Bio-Rad Laboratories Company Details
 Table 57. Bio-Rad Laboratories Business Overview
 Table 58. Bio-Rad Laboratories Latent Tuberculosis Infection Screening Test Product
 Table 59. Bio-Rad Laboratories Revenue in Latent Tuberculosis Infection Screening Test Business (2020-2025) & (US$ Million)
 Table 60. Bio-Rad Laboratories Recent Development
 Table 61. Thermo Fisher Scientific Company Details
 Table 62. Thermo Fisher Scientific Business Overview
 Table 63. Thermo Fisher Scientific Latent Tuberculosis Infection Screening Test Product
 Table 64. Thermo Fisher Scientific Revenue in Latent Tuberculosis Infection Screening Test Business (2020-2025) & (US$ Million)
 Table 65. Thermo Fisher Scientific Recent Development
 Table 66. Sanofi Company Details
 Table 67. Sanofi Business Overview
 Table 68. Sanofi Latent Tuberculosis Infection Screening Test Product
 Table 69. Sanofi Revenue in Latent Tuberculosis Infection Screening Test Business (2020-2025) & (US$ Million)
 Table 70. Sanofi Recent Development
 Table 71. Par Sterile Company Details
 Table 72. Par Sterile Business Overview
 Table 73. Par Sterile Latent Tuberculosis Infection Screening Test Product
 Table 74. Par Sterile Revenue in Latent Tuberculosis Infection Screening Test Business (2020-2025) & (US$ Million)
 Table 75. Par Sterile Recent Development
 Table 76. Research Programs/Design for This Report
 Table 77. Key Data Information from Secondary Sources
 Table 78. Key Data Information from Primary Sources
 Table 79. Authors List of This Report


List of Figures
 Figure 1. Latent Tuberculosis Infection Screening Test Picture
 Figure 2. Global Latent Tuberculosis Infection Screening Test Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Latent Tuberculosis Infection Screening Test Market Share by Type: 2024 VS 2031
 Figure 4. Tuberculin Skin Test (TST) Features
 Figure 5. Interferon Gamma Released Assay (IGRA) Features
 Figure 6. Global Latent Tuberculosis Infection Screening Test Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Latent Tuberculosis Infection Screening Test Market Share by Application: 2024 VS 2031
 Figure 8. Hospital Case Studies
 Figure 9. Diagnostic Laboratories Case Studies
 Figure 10. Others Case Studies
 Figure 11. Latent Tuberculosis Infection Screening Test Report Years Considered
 Figure 12. Global Latent Tuberculosis Infection Screening Test Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Latent Tuberculosis Infection Screening Test Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Latent Tuberculosis Infection Screening Test Market Share by Region: 2024 VS 2031
 Figure 15. Global Latent Tuberculosis Infection Screening Test Market Share by Players in 2024
 Figure 16. Global Top Latent Tuberculosis Infection Screening Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latent Tuberculosis Infection Screening Test as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Latent Tuberculosis Infection Screening Test Revenue in 2024
 Figure 18. North America Latent Tuberculosis Infection Screening Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Latent Tuberculosis Infection Screening Test Market Share by Country (2020-2031)
 Figure 20. United States Latent Tuberculosis Infection Screening Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Latent Tuberculosis Infection Screening Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Latent Tuberculosis Infection Screening Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Latent Tuberculosis Infection Screening Test Market Share by Country (2020-2031)
 Figure 24. Germany Latent Tuberculosis Infection Screening Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Latent Tuberculosis Infection Screening Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Latent Tuberculosis Infection Screening Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Latent Tuberculosis Infection Screening Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Latent Tuberculosis Infection Screening Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Latent Tuberculosis Infection Screening Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Latent Tuberculosis Infection Screening Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Latent Tuberculosis Infection Screening Test Market Share by Region (2020-2031)
 Figure 32. China Latent Tuberculosis Infection Screening Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Latent Tuberculosis Infection Screening Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Latent Tuberculosis Infection Screening Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Latent Tuberculosis Infection Screening Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Latent Tuberculosis Infection Screening Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Latent Tuberculosis Infection Screening Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Latent Tuberculosis Infection Screening Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Latent Tuberculosis Infection Screening Test Market Share by Country (2020-2031)
 Figure 40. Mexico Latent Tuberculosis Infection Screening Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Latent Tuberculosis Infection Screening Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Latent Tuberculosis Infection Screening Test Market Share by Country (2020-2031)
 Figure 44. Turkey Latent Tuberculosis Infection Screening Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Latent Tuberculosis Infection Screening Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Latent Tuberculosis Infection Screening Test Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Qiagen Revenue Growth Rate in Latent Tuberculosis Infection Screening Test Business (2020-2025)
 Figure 48. Oxford Immunotec Revenue Growth Rate in Latent Tuberculosis Infection Screening Test Business (2020-2025)
 Figure 49. Bio-Rad Laboratories Revenue Growth Rate in Latent Tuberculosis Infection Screening Test Business (2020-2025)
 Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Latent Tuberculosis Infection Screening Test Business (2020-2025)
 Figure 51. Sanofi Revenue Growth Rate in Latent Tuberculosis Infection Screening Test Business (2020-2025)
 Figure 52. Par Sterile Revenue Growth Rate in Latent Tuberculosis Infection Screening Test Business (2020-2025)
 Figure 53. Bottom-up and Top-down Approaches for This Report
 Figure 54. Data Triangulation
 Figure 55. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS